Christoph George Baumann
Lecturer in Molecular Biophysics
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Christoph George Baumann is a Lecturer in Molecular Biophysics at the University of York, UK. His research focuses on glyco-engineering of bacterial cell surfaces, virulence-associated proteins in Rhodococcus equi, and the dynamics of ion channel subunits. He has contributed to various studies on physiological responses in bacteria, including motility and DNA packaging mechanisms, as well as developments in treatments for urinary tract infections.
Articles (9)
Year:
2024
Rhodococcus equi is a Gram-positive facultative intracellular pathogen associated with life-threatening bronchopneumonial disease in foals. Key to R. equi’s intracellular survival in host macrophages is the production of virulence associated proteins (Vaps). Numerous vap genes are found on virulence plasmids isolated from different species, and the Vaps share a high degree of sequence identity. VapA has been extensively studied, and although vapK and vapN genes from other R. equi virulence plasmids have been shown to be essential for R. equi intracellular survival, their mode of action is less characterised. We, therefore, examined whether VapK and VapN worked mechanistically in the same way as VapA. Indeed, like VapA, VapK and VapN neutralised lysosomal pH and reduced lysosomal hydrolase activity. A loss of VapA and R. equi virulence could be regained by the presence of either VapK or VapN. The acid-neutralisation activity was also observed to a lesser extent with VapB. There was a differential activity across these virulence-promoting Vaps with the most “acid-neutralising” activity found with VapN, then VapA and K, and finally VapB. These data suggest that VapA production, which is often found in equine infections, can be substituted by VapK and B (produced by plasmids often found in porcine species) or VapN (produced by plasmids often isolated in bovine and human samples). These data imply that the molecular mechanism(s) that VapA uses to neutralise lysosomal acidity should also be seen in VapN and K which will help guide researchers in identifying their precise mode of action and aid the future development of targeted therapeutics.
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Collaborators (18)
Alison Parkin
Anniversary Research Lecturer in Chemistry
University of York
Nathalie Yvonne Micheline Signoret
senior lecturer in Immunology
University of York
Clare Mahon
Assistant Professor, Organic Chemistry
University of Durham
Laurence Wilson
Senior Lecturer (Biophysics)
University of York
James Conway
Professor
University of Pittsburgh
James Moir
Professor
University of York
Thomas F. Krauss
University of York
Michael Plevin
Senior Lecturer in Molecular Biophysics, Royal Society Industry Fellow at University of York
University of York
Paul Jardine
Professor
University of Minnesota
Joseph Gault
AstraZeneca UK Limited
Emanuele Paci
University of Bologna
Jennifer Robyn Potts
University of York
Paul R. Pryor
University of York
Anthony Wilkinson
Professor
University of York
Fiona Whelan
University of Adelaide
Steven David Johnson
Reader
University of York
Herman KH Fung
Assistant Professor
University of Michigan
William Brackenbury
Senior Lecturer in Biomedical Sciences
University of York
Make your next move.
Prepare your application
Review drafts before you send them.